Therefore, the SM-Cer pathway controlled by A-SMase may be a potential target in AD by reducing secretion of proinflammatory factors [18], thereafter preventing formation of astrocyte-derived mitotoxic EVs. The gene discussed is CBLN1; the disease is Alzheimer disease.